Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP810141.RAfw2EqtvW95oHoq-rOx_FHL_8pPPQsr8kTXKJ4JmAaIk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP810141.RAfw2EqtvW95oHoq-rOx_FHL_8pPPQsr8kTXKJ4JmAaIk130_assertion type Assertion NP810141.RAfw2EqtvW95oHoq-rOx_FHL_8pPPQsr8kTXKJ4JmAaIk130_head.
- NP810141.RAfw2EqtvW95oHoq-rOx_FHL_8pPPQsr8kTXKJ4JmAaIk130_assertion description "[p53 overexpression was more common in TA2 (38.3%) than in TA1 (10.0%) (P<0.001) but did not differ from TVA (32.2%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP810141.RAfw2EqtvW95oHoq-rOx_FHL_8pPPQsr8kTXKJ4JmAaIk130_provenance.
- NP810141.RAfw2EqtvW95oHoq-rOx_FHL_8pPPQsr8kTXKJ4JmAaIk130_assertion evidence source_evidence_literature NP810141.RAfw2EqtvW95oHoq-rOx_FHL_8pPPQsr8kTXKJ4JmAaIk130_provenance.
- NP810141.RAfw2EqtvW95oHoq-rOx_FHL_8pPPQsr8kTXKJ4JmAaIk130_assertion SIO_000772 21263241 NP810141.RAfw2EqtvW95oHoq-rOx_FHL_8pPPQsr8kTXKJ4JmAaIk130_provenance.
- NP810141.RAfw2EqtvW95oHoq-rOx_FHL_8pPPQsr8kTXKJ4JmAaIk130_assertion wasDerivedFrom befree-20140225 NP810141.RAfw2EqtvW95oHoq-rOx_FHL_8pPPQsr8kTXKJ4JmAaIk130_provenance.
- NP810141.RAfw2EqtvW95oHoq-rOx_FHL_8pPPQsr8kTXKJ4JmAaIk130_assertion wasGeneratedBy ECO_0000203 NP810141.RAfw2EqtvW95oHoq-rOx_FHL_8pPPQsr8kTXKJ4JmAaIk130_provenance.